Polymorphism of chenodeoxycholic acid.

Area of Science:

• Solid-state chemistry
• Materials science
• Pharmaceutical sciences

Background:

• Chenodeoxycholic acid is a secondary bile acid with pharmaceutical relevance.
• Understanding its solid-state properties is crucial for drug formulation and stability.
• Polymorphism can significantly impact bioavailability and manufacturing processes.

Purpose of the Study:

• To investigate and characterize the polymorphic forms of chenodeoxycholic acid.
• To identify different crystalline and amorphous states of this compound.
• To provide foundational data for its pharmaceutical applications.

Main Methods:

• Differential thermal analysis (DTA) was employed to study thermal transitions.
• X-ray diffraction (XRD) was utilized for structural characterization of the solid forms.
• Combined DTA and XRD enabled comprehensive polymorphic analysis.

Main Results:

• Four distinct polymorphic forms of chenodeoxycholic acid were identified.
• Three of these forms were crystalline, exhibiting unique structural arrangements.
• One amorphous form was also characterized, lacking long-range molecular order.

Conclusions:

• Chenodeoxycholic acid exhibits significant polymorphism.
• The identified crystalline and amorphous forms require distinct handling and formulation strategies.
• Further research can leverage these findings for optimized chenodeoxycholic acid-based therapeutics.